SYMBYX

SYMBYX is an Australian medical technology company that develops light (photobiomodulation) therapies and devices for previously difficult-to-address chronic conditions. SYMBYX's current focus is on managing neurodegenerative diseases such as Parkinson's, ASD, dementia, and metabolic conditions including IBD-Crohn's and diabetes.